
Agrimol B
CAS No. 55576-66-4
Agrimol B ( —— )
产品货号. M18808 CAS No. 55576-66-4
Agrimol B 是从 Agrimonia pilosa Ledeb 中分离出来的主要活性成分。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2697 | 有现货 |
![]() ![]() |
10MG | ¥4026 | 有现货 |
![]() ![]() |
25MG | ¥6699 | 有现货 |
![]() ![]() |
50MG | ¥9153 | 有现货 |
![]() ![]() |
100MG | ¥12393 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Agrimol B
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Agrimol B 是从 Agrimonia pilosa Ledeb 中分离出来的主要活性成分。
-
产品描述Agrimol B is a main active ingredient isolated from Agrimonia pilosa Ledeb.
-
体外实验Cell Cycle Analysis Cell Line:PC-3 and A549 cells Concentration:29 and 63 μM (PC-3), 19 and 76 μM (A549)Incubation Time:10 min Result:Dose-dependently increased cells at G0 in both cell lines. Reduced percentage of cells positive for Ki-67, and increased p27 positive cell population in PC-3 and A549 cells.Western Blot Analysis Cell Line:PC-3 and A549 cells Concentration:0, 29, 49, 63 μM (PC-3); 0, 19, 50, and 76 μM (A549) Incubation Time:3 days Result:Reduced c-MYC, SKP2 and increased p27 in both cell lines, and down-regulated SPT16 and SSRP1 in A549 cells with no effect on CRM1 in both cell lines.Immunofluorescence Cell Line:3T3-L1 preadipocyte Concentration:0, 3, and 10 μM Incubation Time:6 days Result:Significantly increased nuclear positive rate of SIRT1; Markedly increased SIRT1 expression at 10 μM, the effect vanished at 3 μM. Down-regulated PPARγ and C/EBPα (CCAAT/enhancer-binding protein α) expression; Significantly decreased FAS (fatty acid synthesis), UCP-1 (uncoupling protein-1), and apoE (apolipoprotein E) expression at 10 μM.
-
体内实验Animal Model:BALB/c nude mice (6-week-old, male, injected with PC-3 cells in 0.2 mL PBS subcutaneously)Dosage:10 mg/kg Administration:Orally, daily, after 15 days of cancer cell implantation Result:Inhibited tumor growth in a mouse model of human prostate cancer, reduced the tumor volume at day 31 and day 32.
-
同义词——
-
通路Apoptosis
-
靶点NF-κB
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number55576-66-4
-
分子量682.76
-
分子式C37H46O12
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 5.56 mg/mL (8.14 mM)
-
SMILESCCCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(=C(C(=C2O)C(=O)C(C)CC)O)CC3=C(C(=C(C(=C3O)C)OC)C(=O)CCC)O)O)O)C)OC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
NF-κB/MAPK-IN-1
NF-κB/MAPK-IN-1 (compound 11a) 是一种有效的 NF-κB 和 MAPK 通路抑制剂。NF-κB/MAPK-IN-1 对 NO 生成具有抑制作用,其 IC50 为6.96 μM。NF-κB/MAPK-IN-抑制 LPS 诱导的 iNOS,COX-2,ERΚ 和 P38 激活。 NF-κB/MAPK-IN-1 可抑制 LPS 诱导的巨噬细胞炎症反应。 NF-κB/MAPK-IN-1 可用于类风湿关节炎 (RA) 的研究。
-
Gue1654
Gue1654 是 OXE-R 的调节剂。Gue1654 抑制 Gβγ 但不抑制 Gα 信号传导,该信号由化学引诱受体 OXE-R 激活 Gα(i)-βγ 触发。Gue1654 不会直接干扰 Gβγ 处或下游的信号传导。
-
SR12460
SR12460 (SR-12460) 是一种新型 NF-κB 必需调节剂 (NEMO) 结合域 (NBD) 模拟物,用于抑制 IKK/NF-κB 激活。